bearish

Hindalco - Novelis Pain Likely to Persist for Some Time; D/G to SELL

183 Views09 Nov 2024 01:30
Broker
We were not convinced with its steep EBITDA/t improvement trajectory in the medium term and in playing the Bay Minette capex cycle.
What is covered in the Full Insight:
  • Hindalco's Current Stock Evaluation
  • Novelis's Recent Performance
  • EBITDA/t Guidance Withdrawal
  • Impact of China's Scrap Import Policy
  • Outlook and Future Projections
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 20-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Emkay
External broker reports(aggregated public sources)
Emkay Global Financial Services Limited
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x